Historical record - last NADAC effective date: 6/22/2022
Product Information
LINEZOLID 600 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $2.0838 per EA under NDC 62332018320. Its NADAC has been published 325 times since Apr 6, 2016.
FDA first approved this application on Dec 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332018320
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/22/2022
Active Ingredients
LINEZOLIDApproval Type
Generic (ANDA)
FDA Application
ANDA205233FDA Approved
12/21/2015
TE Code
AB
On Market Since
12/22/2015
Pharmacological Classes
Price Statistics
The NADAC for LINEZOLID 600 MG TABLET has been published 325 times since Apr 6, 2016, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0838 per EA |
|---|---|
| All-time high | $10.2781 (Apr 13, 2016) |
| All-time low | $1.8959 (May 18, 2022) |
| Median price | $2.6168 |
| Average price | $3.5967 |
| Largest weekly change | +33.4% (Aug 23, 2017) |
| Weeks tracked | 325 |
| Tracking since | Apr 6, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-7.5%
All
-79.7%
Last surveyed Jun 22, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Linezolid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Oxazolidinone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LINEZOLID 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LINEZOLID 600 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $2.0838 per EA (NDC 62332018320), effective Jun 22, 2022.
How has the price of LINEZOLID 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for LINEZOLID 600 MG TABLET has declined 79.7%. It has been tracked across 325 weekly CMS publications since Apr 6, 2016.
What are the highest and lowest recorded NADAC prices for LINEZOLID 600 MG TABLET?
Since Apr 6, 2016, the NADAC for LINEZOLID 600 MG TABLET has ranged from a low of $1.8959 (May 18, 2022) to a high of $10.2781 (Apr 13, 2016), with a median of $2.6168 per EA.
Are there cheaper alternatives to LINEZOLID 600 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LINEZOLID 600 MG TABLET, is $1.4411 per EA — about 31% below LINEZOLID 600 MG TABLET.
Who manufactures LINEZOLID 600 MG TABLET?
LINEZOLID 600 MG TABLET (NDC 62332018320) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.